632. CAN CARDIOPULMONARY EXERCISE TESTING PREDICT NEOADJUVANT CHEMOTHERAPY TOXICITY IN OESOPHAGEAL ADENOCARCINOMA PATIENTS?

Abstract Background Cardiopulmonary exercise testing (CPET) is a method of assessing cardiopulmonary fitness. In the context of surgery, it is used to risk-stratify patients, allowing targeted prehabilitation to optimise comorbidities and fitness prior to surgery, and triage patients to the appropriate level of care after the operation. Various CPET-derived variables have been shown to be associated with short- and long-term outcomes after various surgery. In patients post-oesophagectomy, these variables are predictive of long-term survival. This study aimed to assess the use of this tool to predict neoadjuvant chemotherapy (NAC) related complications in patients receiving neoadjuvant FLOT prior to oesophagectomy. Methods All patients who underwent routine CPET during the staging process prior to NAC with FLOT and oesophagectomy in a single high-volume centre between September 2018 and January 2023 were included. Data were extracted from the unit’s contemporaneously maintained database. The Mann-Whitney U test was used to compare CPET variables in patients who completed NAC with FLOT fully versus those who did not finish NAC with FLOT due to acute chemotherapy toxicities. Results There were 129 patients who received neoadjuvant FLOT and had routine CPET performed during the defined study period. Six of those patients (4.7%) did not complete neoadjuvant chemotherapy due to acute chemotherapy toxicities but progressed to surgery. The median anaerobic threshold, VO2 peak, and VE/VCO2 among those who completed NAC were 14.2 ml/kg/min, 20.3 ml/kg/min, and 28, respectively, compared to 13.4 ml/kg/min, 19.7 ml/kg/min, and 31 in those who did not complete NAC (p=0.595, p=0.695, and p=0.160, respectively). Conclusion Although patients who received all four cycles of NAC with FLOT prior to oesophagectomy demonstrated CPET values indicating better base-line fitness than those who had to discontinue NAC due to acute chemotherapy toxicity, these differences did not reach the level of statistical significance. This study, therefore, did not demonstrate any predictive value of CPET in assessing the risk of incomplete NAC treatment prior to oesophagectomy.

Authors

Institutions

Publication Details

Journal
Diseases of the Esophagus
Published
2024-09-01
DOI
https://doi.org/10.1093/dote/doae057.337
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

632. CAN CARDIOPULMONARY EXERCISE TESTING PREDICT NEOADJUVANT CHEMOTHERAPY TOXICITY IN OESOPHAGEAL ADENOCARCINOMA PATIENTS?

Jakub Chmelo, R. C. F. Sinclair, Alexander Bradshaw, Abbienaya Dayanamby et al.
Diseases of the Esophagus
Lung Cancer Diagnosis and Treatment
article

632. CAN CARDIOPULMONARY EXERCISE TESTING PREDICT NEOADJUVANT CHEMOTHERAPY TOXICITY IN OESOPHAGEAL ADENOCARCINOMA PATIENTS?

Jakub Chmelo, R. C. F. Sinclair, Alexander Bradshaw, Abbienaya Dayanamby, Alexander W. Phillips
article en

Abstract

Abstract Background Cardiopulmonary exercise testing (CPET) is a method of assessing cardiopulmonary fitness. In the context of surgery, it is used to risk-stratify patients, allowing targeted prehabilitation to optimise comorbidities and fitness prior to surgery, and triage patients to the appropriate level of care after the operation. Various CPET-derived variables have been shown to be associated with short- and long-term outcomes after various surgery. In patients post-oesophagectomy, these variables are predictive of long-term survival. This study aimed to assess the use of this tool to predict neoadjuvant chemotherapy (NAC) related complications in patients receiving neoadjuvant FLOT prior to oesophagectomy. Methods All patients who underwent routine CPET during the staging process prior to NAC with FLOT and oesophagectomy in a single high-volume centre between September 2018 and January 2023 were included. Data were extracted from the unit’s contemporaneously maintained database. The Mann-Whitney U test was used to compare CPET variables in patients who completed NAC with FLOT fully versus those who did not finish NAC with FLOT due to acute chemotherapy toxicities. Results There were 129 patients who received neoadjuvant FLOT and had routine CPET performed during the defined study period. Six of those patients (4.7%) did not complete neoadjuvant chemotherapy due to acute chemotherapy toxicities but progressed to surgery. The median anaerobic threshold, VO2 peak, and VE/VCO2 among those who completed NAC were 14.2 ml/kg/min, 20.3 ml/kg/min, and 28, respectively, compared to 13.4 ml/kg/min, 19.7 ml/kg/min, and 31 in those who did not complete NAC (p=0.595, p=0.695, and p=0.160, respectively). Conclusion Although patients who received all four cycles of NAC with FLOT prior to oesophagectomy demonstrated CPET values indicating better base-line fitness than those who had to discontinue NAC due to acute chemotherapy toxicity, these differences did not reach the level of statistical significance. This study, therefore, did not demonstrate any predictive value of CPET in assessing the risk of incomplete NAC treatment prior to oesophagectomy.

Diseases of the EsophagusVol. 37(Supplement_1)
Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Newcastle University (GB)
Good health and well-being
Openalex Percentile: Top 74%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.